Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
NCT06069076 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2023-10-13
Summary
1. Evulate the diagnostic value of serum cathepsin S and chromogranin A for Diabetic kidney disease.
2. To correlate the levels of serum Cathepsin S and chromogranin A with HbA1c and eGFR in type 2 diabetic patients based on urinary Albumin- Creatinine Ratio.
Conditions
- Diabetic Kidney Disease
Interventions
- DIAGNOSTIC_TEST
-
cathepsin S and chromogranin A
Diagnostic value of serum Cathepsin S and Chromogranin A
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2025-10-01
- Completion
- 2026-10-01
More Related Trials
-
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
NCT01101269 ·Status: TERMINATED ·Phase: NA
-
Fib to Alb Ratio in Type 2 Dkd
NCT05691985 ·Status: NOT_YET_RECRUITING
-
Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy
NCT03212755 ·Status: UNKNOWN ·Phase: NA
-
Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes
NCT04127084 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
NCT06668753 ·Status: NOT_YET_RECRUITING
-
An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy
NCT01273675 ·Status: UNKNOWN
-
Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients
NCT07302464 ·Status: COMPLETED
-
Compare Serum Klotho Levels in Patients on Oral Antidiabetic Treatment
NCT03585777 ·Status: UNKNOWN
-
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
NCT05373004 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
NCT00407680 ·Status: UNKNOWN ·Phase: PHASE4
-
Empagliflozin in Patients With Glomerulonephritis
NCT05283057 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
NCT07173686 ·Status: NOT_YET_RECRUITING
-
Use of Sitagliptin to Decrease Microalbuminuria
NCT02048904 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
NCT05687890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?
NCT04853615 ·Status: UNKNOWN
-
Matrix Metalloproteinases and Diabetic Nephropathy
NCT00067886 ·Status: COMPLETED
-
To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy
NCT01163591 ·Status: COMPLETED
-
GLUcose Transport and REnalPROtection in Chronic Kidney Disease
NCT05998837 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Molecular Analysis of Diabetic Kidney Disease Biopsies
NCT04029402 ·Status: RECRUITING
-
Insulin Resistance, Sarcopenia and Plasma BAIBA Levels
NCT04309201 ·Status: COMPLETED
-
Predicting Response to Incretin Based Agents in Type 2 Diabetes
NCT01503112 ·Status: COMPLETED
-
Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value
NCT06123871 ·Status: ACTIVE_NOT_RECRUITING
-
Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes
NCT02580266 ·Status: WITHDRAWN
-
Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein
NCT05922852 ·Status: UNKNOWN
-
Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk
NCT05520684 ·Status: UNKNOWN